
Fido Life Sciences Private Limited
About Fido Life Sciences Private Limited
Data last updated:
Fido Life Sciences Private Limited is a private limited company based in Baghpat, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 11 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2017PTC097729.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Ipfizen Pharmaceuticals Private Limited. It is led by directors Sandeep Kumar and Pradeep Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhagot Kh. Ash. Chandinagar Bagpat, Baghpat, Uttar Pradesh, India – 250101.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.2 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹8,122 (net margin 0.6%) and EBITDA of ₹9,624 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fido Life Sciences Private Limited's registered office is in Baghpat, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressBhagot Kh. Ash. Chandinagar Bagpat, Baghpat, Uttar Pradesh, India – 250101
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Fido Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fido Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Fido Life Sciences Private Limited, buy the company report.
Financials of Fido Life Sciences Private Limited
FY 2025 filings availableFido Life Sciences Private Limited reported revenue of ₹14.2 Lakh (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 2% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9,624 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,122 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fido Life Sciences Private Limited, buy the company report.
Board of directors of Fido Life Sciences Private Limited
Fido Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
| Pradeep Kumar | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Fido Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medistra Remedies Private Limited | ₹14.28 Lakh (FY 2025) | 30.0% | Bhopal, Madhya Pradesh, India | |||
| Menorah Consumer Products Private Limited | ₹14.27 Lakh (FY 2022) | -44.0% | Nagercoil, Tamil Nadu, India | |||
| Vastav Life Sciences Private Limited | ₹14.25 Lakh (FY 2021) | Guwahati, Assam, India | ||||
| Maestria Paints India Private Limited | ₹14.23 Lakh (FY 2021) | -97.0% | Hyderabad, Telangana, India | |||
| S D Finexpo Commercial (India) Pvt Ltd | ₹14.21 Lakh (FY 2025) | 42.0% | Kolkata, West Bengal, India | |||
| Fido Life Sciences Private Limitedthis company | ₹14.2 Lakh (FY 2024) | ₹8,122 | 0.6% | 2.0% | Baghpat, Uttar Pradesh, India | |
| Abeers Pharmaceuticals Private Limited | ₹14.2 Lakh (FY 2024) | Delhi, India | ||||
| Kain Cosmeceuticals Private Limited | ₹14.19 Lakh (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Staylife Medical Services Private Limited | ₹14.19 Lakh (FY 2016) | Chennai, Tamil Nadu, India | ||||
| Xpertise Pharma Private Limited | ₹14.18 Lakh (FY 2017) | 18.0% | Mohali, Punjab, India | |||
| Shifa Laboratories Pvt Ltd | ₹14.18 Lakh (FY 2025) | -78.0% | New Delhi, Delhi, India |
To see the full peer comparison of Fido Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fido Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fido Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Fido Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Fido Life Sciences Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Manpreet Kaur ceased to be Director on 23 Jun 2020.
Frequently asked questions
Fido Life Sciences is an active private limited company based in Baghpat, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 11 October 2017 (9+ years old) and is registered under CIN U74999UP2017PTC097729.
Fido Life Sciences has 2 current directors:
- Sandeep Kumar - Director
- Pradeep Kumar - Director
The latest financial statements of Fido Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Fido Life Sciences is U74999UP2017PTC097729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fido Life Sciences was incorporated on 11 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Fido Life Sciences by revenue are Medistra Remedies Private Limited, Menorah Consumer Products Private Limited, Vastav Life Sciences Private Limited, Maestria Paints India Private Limited, S D Finexpo Commercial (India) Pvt Ltd and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manpreet Kaur ceased to be Director on 23 Jun 2020. Vijay Sharma ceased to be Director on 23 Jun 2020. Pradeep Kumar was appointed as Director on 22 Jun 2020. Fido Life Sciences has 4 board changes on record in total.
The registered office of Fido Life Sciences is at Bhagot Kh. Ash. Chandinagar Bagpat, Baghpat, Uttar Pradesh, India – 250101.
Fido Life Sciences operates in the business services industry, in the other services segment.
The compliance status of Fido Life Sciences is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.
Yes. Fido Life Sciences was formerly known as Ipfizen Pharmaceuticals Private Limited.

